VARIANTS OF DR3 AND USE THEREOF

Amir Aharoni (Inventor), Itay Levin (Inventor)

Research output: Patent

Abstract

Death-domain receptor 3 (DR3)variants having increased binding affinity to TL1A,and composition comprising same,are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.

Original languageAmerican English
Patent numberWO2015166486
IPCA61P 29/ 00 A I
Priority date28/04/14
StatePublished - 5 Nov 2015

Fingerprint

Dive into the research topics of 'VARIANTS OF DR3 AND USE THEREOF'. Together they form a unique fingerprint.

Cite this